Skip to main content
Fig. 1 | Trials

Fig. 1

From: Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Fig. 1

Comparison of usual care with standardized frequency and timing of follow-up for GOSPEL I components. Med history will be informed by pharmacy review prior to the SCN Clinic. Three-monthly follow-up schedule: flexibility 3 weeks ± the scheduled GP and specialist appointment permitted. Six-monthly follow-up schedule: flexibility 8 weeks ± the scheduled GP and specialist appointment permitted. > 2 years follow-up for usual care: indolent lymphoma, ongoing 6-monthly specialist review; aggressive lymphoma, 6-monthly specialist review (years 2–3), annual specialist review (years 3–5), discharge to GP after 5 years. SNC, Specialist Cancer Nurse; Tx, treatment; SCP, Survivorship Care Plan; Med, mediation; GP, general practitioner; H&P, history and physical examination. “History” includes review of patient experience of fevers, sweats, loss of weight, infections; “Physical Examination” includes check for lymphadenopathy, splenomegaly ± hepatomegaly; “Bloods” includes order and review of full blood count, urea and electrolytes, liver function tests, and lactate dehydrogenase. If the patient’s hematologist notes that additional clinic visits are clinically indicated, then they can schedule additional appointments

Back to article page